3196 results for «632»
3196 results
Rapid-fire abstracts: Session 5
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of right ventricular dysfunction on the outcomes of TAVI - Insights from nationwide database, impact of COVID-19 pandemic on TAVI activity: a worldwide registry, redo isolated tricuspid valve surgery - Prediction of...
Rapid-Fire clinical cases: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?
09 Jul 2019
An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...
Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial
27 Oct 2025
Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.
Author
EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....
Transcatheter edge-to-edge repair of functional mitral regurgitation in heart failure: Final five-year results from the COAPT Trial
06 Mar 2023
Alex Sticchi & Jonathan Curio provide their take on the clinical trial presented by Gregg W. Stone at the American College of Cardiology Scientific Sessions (ACC.23/WCC).
Author
Author
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.
Author
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
